cARDIAC BIOMARKERS IN CHRONIC KIDNEY DISEASE AND THEIR RELATIONSHIP TO VASCULAR OUTCOMES

Analysis of Serum Advanced Glycation Endproducts Reveals Methylglyoxal-Derived Advanced Glycation MG-H1 Free Adduct Is a Risk Marker in Non-Diabetic and Diabetic Chronic Kidney Disease

N Rabbani, A Adaikalakoteswari, JR Larkin, S Panagiotopoulos, RJ MacIsaac, DK Yue, GR Fulcher, MA Roberts, M Thomas, E Ekinci, PJ Thornalley

2023-01-01

Accumulation of advanced glycation endproducts (AGEs) is linked to decline in renal function, particularly in patients with diabet..

Serial increased cardiac troponin T predicts mortality in asymptomatic patients treated with chronic haemodialysis

MA Roberts, DL Hare, N Macmillan, S Ratnaike, K Sikaris, FL Ierino

2009-07-01

Background: A single detectable cardiac troponin predicts mortality in patients treated with dialysis. There are limited data on c..

B-type natriuretic peptides strongly predict mortality in patients who are treated with long-term dialysis

MA Roberts, PM Srivastava, N Macmillan, DL Hare, S Ratnaike, K Sikaris, FL Ierino

2008-01-01

Background and objectives: Left ventricular abnormalities contribute to cardiovascular disease in patients with chronic kidney dis..

Cardiac troponin levels in asymptomatic patients on the renal transplant waiting list

MA Roberts, N Macmillan, DL Hare, S Ratnaike, K Sikaris, MB Fraenkel, FL Ierino

2006-10-01

Aims: Cardiac troponin levels predict mortality and cardiovascular events in asymptomatic patients receiving dialysis and may be a..

Low molecular weight advanced glycation end products predict mortality in asymptomatic patients receiving chronic haemodialysis

MA Roberts, MC Thomas, D Fernando, N Macmillan, DA Power, FL Ierino

2006-06-01

Background. Advanced glycation end products (AGEs) have biological properties that may contribute to the premature cardiovascular ..